Butalbital, Acetaminophen, And Caffeine Tablet
FDA Label NDC 0904-6938

31 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Butalbital, Acetaminophen, And Caffeine (NDC 0904-6938). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, hepatotoxicity, description, clinical pharmacology, pharmacokinetics, butalbital, acetaminophen, caffeine, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-6938-06

Unit Dose

Butalbital,

Acetaminophen, and

Caffeine

Tablets, USP

50 mg/325 mg/40 mg

50 TABLETS (5 x 10)

Rx only

50mg/325mg/40mg Carton Label (315b8ce7 Eba3 4035 A5ab 4853ba0bb646 00)

50mg/325mg/40mg Carton Label (315b8ce7 Eba3 4035 A5ab 4853ba0bb646 00)

* Please review the disclaimer below.